key: cord-0929395-rhswh2rf authors: Deputy, M; Rao, C; Worley, G; Balinskaite, V; Bottle, A; Aylin, P; Burns, E M; Faiz, O title: Effect of the SARS-CoV-2 pandemic on mortality related to high-risk emergency and major elective surgery date: 2021-03-20 journal: Br J Surg DOI: 10.1093/bjs/znab029 sha: 54f630879ed73f930703238012233014b341441f doc_id: 929395 cord_uid: rhswh2rf These data show large reductions in both elective and emergency activity that are concerning for unmeasured morbidity and mortality within the community. The risk of mortality following high-risk EGS and major elective surgery during the first wave of the pandemic did not differ when compared with date-matched patient cohorts from 2019. The prevalence of concomitant SARS-CoV-2 infection in this surgical population is low. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a significant impact on the provision of surgery globally. Early reports 1-3 of significant morbidity and mortality in surgical patients with SARS-CoV-2 has led to treatment delays and secondary harm in some cases. There is an urgent need to establish the true impact of SARS-CoV-2 on the risks associated with major elective and emergency surgery in comparison with 'normal' practice. The aim of this study was to compare the case mix and mortality of major elective and high-risk emergency surgery in England during the pandemic against the preceding year. The Hospital Episode Statistics (HES) Admitted Patient Care database was interrogated to identify admitted care episodes for adult patients with diagnostic codes relating to high-risk emergency general surgical (EGS) conditions (defined by an associated crude mortality rate greater than 5 per cent 4,5 including gastrointestinal ulcer; hernia, bowel ischaemia, bowel obstruction, diverticulitis, peritonitis, liver and biliary conditions, and miscellaneous; Table S1 and Appendix S1), and major elective surgery across several surgical subspecialties (colectomy, any rectal resection (proctectomy) 6 , cystectomy (bladder) 7 , oesophagectomy, gastrectomy, pancreatectomy, coronary artery bypass graft) 8 , open abdominal aortic aneurysm (AAA) repair 9 , endovascular aortic aneurysm repair (EVAR) 9 , and carotid endarterectomy 10 ; Table S2 and Appendix S1) 11, 12 . Full details of the study methodology, including statistical analysis, are described in Appendix S1. The cohorts were matched by calendar date, diagnostic codes, procedural codes and admission method. Patients with invalid data recorded for age or sex were excluded. The start date was 3 February 2020 before the national lockdown. The end date was 2 August 2020, 12 weeks after the national lockdown. A datematched cohort from 2019 was compared. Case mix and mortality in 2020 were compared with values in 2019. Concurrent SARS-CoV-2 was identified, in any secondary diagnostic field within the same episode, by the emergency ICD-10 codes: U071 (SARS-CoV-2 confirmed by laboratory testing) or U072 (clinical or epidemiological SARS-CoV-2 where laboratory confirmation was inconclusive or not available). Thirty-day mortality was defined as a death occurring in hospital within 30 days of admission. Logistic regression analysis was performed to adjust for potential confounders of mortality. Adjusted odds ratios (ORs) for SARS-CoV-2 infection and year of admission were calculated. Between February and August 2020, 49 889 patients were admitted, representing a 15.0 per cent reduction in high-risk EGS admissions compared with 2019 ( Fig. 1 and Table 1 ). The rate of laparoscopy was proportionally less in 2020 (3.0 per cent versus 3.6 per cent in 2019; P < 0.0001). The 30-day mortality rate was unchanged between 2020 and 2019 (8.8 versus 8.5 per cent respectively; P ΒΌ 0.068). In the 2020 cohort, 2.1 per cent of patients (1027 of 49 889) were diagnosed with SARS-CoV-2 infection. The 30-day mortality rate for high-risk EGS admissions was 8.8 per cent overall, compared with 16.7 per cent in patients with concurrent SARS-CoV-2 infection ( Table 3) . Logistic regression analysis was performed to investigate the impact of concurrent SARS-CoV-2 on 30-day mortality. Adjusting for potential confounders of age, sex, ethnicity, Carstairs quintile, Table 3) . Year of admission was not a significant confounder. Some 14 721 patients were admitted in 2020, a reduction of 37.6 per cent from 2019 ( Fig. 2 and Table 2 ). The volume of carotid endarterectomy decreased by 42.5 per cent, open AAA repair by 51.7 per cent, EVAR by 51.6 per cent, gastrectomy by 62.2 per The coronavirus pandemic has had a significant impact on the provision of surgery globally. This research looked at how the pandemic has affected rates of surgery in England using administrative data. Specifically, it examined the characteristics of patients who were admitted and mortality when patients contracted coronavirus. It found that the overall risk of death did not change in 2020 compared with the same time period in 2019. It did find that the risk of death increased with coronavirus infection. The authors recommend preventive measures to ensure patient safety when restarting elective surgery during the pandemic. Table 3) . Year of admission was not a significant confounder. SARS-CoV-2 cases amongst high-risk EGS admissions and major elective surgery by week before and during the pandemic are shown in Fig. S1 . Additional analyses are presented in full in Appendix S2. This study has suggested that mortality associated with high-risk EGS admissions and major elective surgery undertaken during the first wave of the pandemic was not increased. Although the number of patients with concurrent SARS-CoV-2 infection was extremely low, mortality was significantly increased in this group, justifying preventive measures. In SARS-CoV-2-positive patients, or patients with significant co-morbidity, the findings of this study support consideration of non-surgical management strategies, where safe. The mortality rate associated with SARS-CoV-2 was significantly less than reported previously, although the populations are not directly comparable [1] [2] [3] 13 . This is possibly due to a lack of inclusion bias in HES data. Second, these data did not aggregate outcomes from different healthcare systems, at different stages of their pandemic curve. Most of the reported literature has originated from North America and Europe, but some are from healthcare systems without equivalent resources to mitigate risk. Finally, this study encompasses a longer period, not relying solely on data from early in the pandemic, when there was less testing and under-representation of patients with minimally symptomatic SARS-CoV-2 infection. The present experience is, however, congruent with smaller, statistically matched, cohort studies from the literature 14 . It is unclear why SARS-CoV-2 infection results in proportionally greater mortality in elective compared with emergency surgery, although this may be multifactorial. This study used administrative healthcare data with quantified accuracy 15, 16 . These data must be interpreted with caution given the novelty of the SARS-CoV-2 ICD-10 code 17 . It is feasible that the code was not employed consistently during the pandemic (used for major pulmonary complications not due to SARS-CoV-2), as this study found that one-quarter of SARS-CoV-2 diagnoses were not based on laboratory confirmation. HES data do not include BMI, which influences prognosis 18 . This study was unable to differentiate whether patients acquired SARS-CoV-2 before or during hospital inpatient admission. Patients may have contracted SARS-CoV-2 in the community after discharge and therefore were not captured by this methodology, potentially leading to under-reporting. It was also impossible to differentiate between symptomatic and asymptomatic patients, along with the possible impact of a gradual increase in routine preoperative swabbing 19 . The primary outcome measure was mortality. Morbidity associated with SARS-CoV-2 was not investigated. Several strategies were advocated during the first wave of the pandemic to mitigate surgical risk, including non-operative strategies where appropriate, avoidance of laparoscopy, and minimizing anastomosis in favour of defunctioning stomas in colorectal surgery 20 . The extent to which these strategies were adopted, and their efficacy, was not investigated. Although the relationship between geographical region and mortality was beyond the scope of this study, it will be the focus of future research. There was a marked volume reduction for high-risk emergency general and major elective surgery. No evidence was found to support a change in patient demographics. It is likely that some high-risk surgery was deferred either by patients or by the health service. It is unknown to what extent harm has occurred within the latter patient groups. There were large reductions in both elective and EGS activity that are concerning for unmeasured morbidity and mortality. Concurrent SARS-CoV-2 infection in patients undergoing surgery significantly increased the mortality risk. However, infection rates in surgical pathways during the first wave of the pandemic in England were low. Continued safe operating throughout the pandemic will be important to mitigate indirect harm to patients incurred through treatment delays, and work must continue to develop safe pathways for this to happen. The overall mortality risk associated with high-risk emergency general and major elective surgery in the first wave of the pandemic did not differ from that in historical controls. Disclosure: The authors declare no conflict of interest. Supplementary material is available at BJS online. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Identification and characterisation of the high-risk surgical population in the United Kingdom Mortality in high-risk emergency general surgical admissions Inequalities in implementation and different outcomes during the growth of laparoscopic colorectal cancer surgery in England: a national population-based study from 2002 to 2012 The volume-outcome relationship for radical cystectomy in England: an analysis of outcomes other than mortality Identifying cardiac surgery operations in hospital episode statistics administrative database, with an OPCS-based classification of procedures, validated against clinical data Long-term survival after endovascular and open repair of unruptured abdominal aortic aneurysm Inter-relationship of procedural mortality rates in vascular surgery in England: retrospective analysis of hospital episode statistics from Surgeon volume and operative mortality in the United States Hospital stay amongst patients undergoing major elective colorectal surgery: predicting prolonged stay and readmissions in NHS hospitals Factors associated with surgical mortality and complications among patients with and without coronavirus disease 2019 (COVID-19) in Italy Dutch Surgical C-RC. Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: a Dutch, multicenter, matched-cohort clinical study Systematic review of discharge coding accuracy Comparison of administrative data with the Association of Coloproctology of Great Britain and Ireland (ACPGBI) colorectal cancer database International Guidelines for Certification and Classification (Coding) Of Covid-19 as Cause of Death COVID 19 and the patient with obesity-the editors speak out Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic Association of Surgeons of Great Britain and Ireland, Association of Coloproctology of Great Britain and Ireland, Association of Upper Gastrointestinal Surgeons, Royal College of Surgeons of Edinburgh Health). P.A. is also funded through the National Institute for Health Research (NIHR) Patient Safety Translational Research Centre, Imperial College London. The authors are also grateful for support from the NIHR under the Applied Health Research programme for North West London and the NIHR Imperial Biomedical Research Centre. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health. This work used data provided by patients and collected by the NHS as part of their care and support.